Easywell Biomedicals, Inc. (TPEX: 1799)

Easywell Biomedicals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	8,287	4,785	1,836	2,598	2,418	1,243
Market Cap Growth	523.99%	160.70%	-29.34%	7.42%	94.50%	14.35%
Enterprise Value	8,269	4,891	1,862	2,498	2,501	1,552
Last Close Price	68.00	40.85	15.88	22.47	24.52	13.96
PS Ratio	21.98	17.62	10.26	13.17	9.03	3.45
PB Ratio	11.19	7.67	2.38	2.85	3.17	1.78
P/TBV Ratio	26.83	10.48	3.22	3.74	4.29	2.37
EV/Sales Ratio	22.87	18.01	10.41	12.66	9.34	4.31
Debt / Equity Ratio	0.55	0.62	0.45	0.36	0.41	0.61
Asset Turnover	0.28	0.23	0.15	0.17	0.23	0.33
Inventory Turnover	1.48	2.93	4.33	5.67	9.38	54.43
Quick Ratio	2.89	3.26	5.67	13.08	5.35	1.56
Current Ratio	4.02	3.98	6.43	14.10	6.30	2.01
Return on Equity (ROE)	-23.29%	-24.41%	-20.02%	-20.35%	-25.31%	-36.08%
Return on Assets (ROA)	-7.79%	-8.52%	-8.27%	-11.17%	-8.70%	-12.38%
Return on Capital (ROIC)	-8.84%	-9.55%	-8.55%	-11.43%	-9.02%	-13.39%
Earnings Yield	-1.78%	-3.03%	-8.77%	-5.79%	-7.17%	-21.86%
FCF Yield	-2.66%	-3.54%	-3.32%	-5.24%	-7.23%	-15.53%
Buyback Yield / Dilution	-2.15%	-0.05%	-7.48%	-14.08%	-21.77%	-10.70%
Total Shareholder Return	-2.15%	-0.05%	-7.48%	-14.08%	-21.77%	-10.70%

Source: S&P Capital IQ. Standard template. Financial Sources.